Bristol-Myers Squibb Company
(BMY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 16,560,000 | 15,879,000 | 16,385,000 | 17,621,000 | 21,244,000 |
| Cost of Goods | 3,909,000 | 3,932,000 | 4,619,000 | 4,610,000 | 5,598,000 |
| Gross Profit | 12,651,000 | 11,947,000 | 11,766,000 | 13,011,000 | 15,646,000 |
| Operating Expenses | 10,574,000 | 9,566,000 | 8,875,000 | 8,841,000 | 8,665,000 |
| Operating Income | 2,077,000 | 2,381,000 | 2,891,000 | 4,170,000 | 6,981,000 |
| Other Income | 0 | 0 | 0 | -1,830,000 | 0 |
| Pre-tax Income | 2,077,000 | 2,381,000 | 2,891,000 | 2,340,000 | 6,981,000 |
| Income Tax | 446,000 | 352,000 | 311,000 | -161,000 | 1,721,000 |
| Net Income Continuous | 1,631,000 | 2,029,000 | 2,580,000 | 2,501,000 | 5,260,000 |
| Minority Interests | 66,000 | 25,000 | 17,000 | 541,000 | 1,551,000 |
| Net Income | $1,565,000 | $2,004,000 | $2,563,000 | $1,960,000 | $3,709,000 |
| EPS Basic Total Ops | 0.94 | 1.21 | 1.56 | 1.17 | 2.18 |
| EPS Basic Continuous Ops | 0.98 | 1.22 | 1.57 | 1.50 | 3.09 |
| EPS Diluted Total Ops | 0.93 | 1.20 | 1.54 | 1.16 | 2.16 |
| EPS Diluted Continuous Ops | 0.97 | 1.22 | 1.55 | 1.48 | 3.06 |
| EBITDA(a) | $2,453,000 | $2,848,000 | $3,654,000 | $5,143,000 | $7,609,000 |